These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis. Chang PY; Yang CT; Cheng CH; Yu KH Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989 [TBL] [Abstract][Full Text] [Related]
6. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis. Maraina CH; Nurdayana AK; Rusni D; Azwany Y Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies to citrullinated proteins in rheumatoid arthritis]. Matsui T Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):49-56. PubMed ID: 16651702 [TBL] [Abstract][Full Text] [Related]
9. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089 [TBL] [Abstract][Full Text] [Related]
10. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921 [TBL] [Abstract][Full Text] [Related]
11. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis]. Cho SY; Kang SY; Lee HJ; Lee WI Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254 [TBL] [Abstract][Full Text] [Related]
12. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis. Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044 [TBL] [Abstract][Full Text] [Related]
13. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904 [TBL] [Abstract][Full Text] [Related]
14. [New diagnostic and evaluative tests for rheumatoid arthritis]. Hayashi N; Nishimura K; Morinobu A; Kumagai S Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525 [TBL] [Abstract][Full Text] [Related]
16. [Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis]. Araki C; Hayashi N; Moriyama M; Morinobu S; Mukai M; Koshiba M; Kawano S; Kumagai S Rinsho Byori; 2004 Dec; 52(12):966-72. PubMed ID: 15675342 [TBL] [Abstract][Full Text] [Related]
17. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
19. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]